NFKB1 and familial pancreatic carcinoma: Moreover, in pancreatic cancer cells the expression of CXCL12 can be further upregulated by gemcitabine in a NF-κB-dependent fashion, and is subsequently associated with an increased proliferation and drug resistance [60,62].